TuesdayAug 20, 2019 9:19 am

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) to Commence Trading on the Toronto Stock Exchange on August 22

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has received final approval to list its common shares on the Toronto Stock Exchange (“TSX”). The company’s common shares will start trading on the TSX when the market opens on Thursday, August 22, 2019, under the symbol ‘OGI’. In order to ensure continuous trading for the company’s shareholders during the uplisting, Organigram’s shares will be delisted from the TSX Venture Exchange (“TSX.V”) at the beginning of trading on the TSX. To view the full press release, visit…

Continue Reading

MondayAug 19, 2019 11:55 am

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Receives Media Attention following Release of Strong Results

Organigram’s Q3 results marked its fourth quarter in a row of positive adjusted EBITDA* A Bloomberg article states that the company is an outlier due to its high margins and low production costs Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) stands out from other Canadian cannabis companies due to the fact that it has registered four quarters of positive adjusted earnings before interest, taxes, depreciation and amortization (EBITDA), as a Bloomberg article about the enterprise reads (http://ibn.fm/BUMhB). Adjusted EBITDA is a non-IFRS measure. For more information, see the company’s latest MD&A. Organigram’s Q3 and fiscal year-to-date results represent some of the…

Continue Reading

TuesdayAug 13, 2019 2:58 pm

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Develops Technology to Provide Rapid-Onset of Cannabinoid Effects

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, has developed a unique, proprietary nano-emulsification technology that is anticipated to deliver an initial onset of effects within 10 to 15 minutes for cannabis beverages (http://ibn.fm/zy5Pt). A recent article discussing the company reads, “Organigram focuses on high-quality, indoor-grown cannabis for both medical patients and adult-recreational users. Its proprietary technology allows for the development of products with a quick onset of the cannabinoid effect within 10 to 15 minutes. To determine the onset of the products, Organigram studied cannabinoid particles at a size…

Continue Reading

FridayAug 09, 2019 9:27 am

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Receives Conditional Approval to Uplist to the TSX

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, on Thursday announced that it has received conditional approval from the Toronto Stock Exchange (“TSX”) to uplist its common shares from the TSX Venture Exchange (“TSXV”). Per the update, final approval of the listing is subject to OGI satisfying specific customary conditions required by the TSX. After meeting the final listing requirements, Organigram’s common shares will be delisted from the TSXV and begin trading on the TSX under the symbol ‘OGI’. “Graduating to the TSX is a significant milestone for us as…

Continue Reading

MondayJul 29, 2019 3:10 pm

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Increases Licensed Production Capacity

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, recently obtained approval from Health Canada for the licensing of all of the company’s Phase 4A buildout plans, increasing its total licensed production capacity to 61,000 kg. per year (http://ibn.fm/jGAdq). An article discussing the company reads, “Once fully licensed and operational, the full Phase 4 expansion is expected to bring the company’s annualized target production capacity to approximately 113,000 kg. of dried-flower equivalents. . . . ‘Organigram’s continued expansion reflects ongoing growth in the cannabis marketplace, including increasing demand as new retail stores…

Continue Reading

FridayJul 26, 2019 9:42 am

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Gains Access to 60,000kg of CBD-rich Hemp through New Advance Purchase Agreement

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has entered into an advance payment and purchase agreement with 703454 N.B. Inc. (carrying on business as 1812 Hemp). In accordance with the agreement, OGI will pre-fund hemp purchases to receive access to as much as 60,000 kilograms of dried hemp flower to be harvested during 2019 for extraction into cannabidiol (“CBD”) isolate. In January, the company entered into a purchase agreement with 1812 Hemp which granted OGI the first a right of first refusal on 1812 Hemp’s…

Continue Reading

MondayJul 15, 2019 9:47 am

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Reports Q3 Fiscal 2019 Results, Hosts Earnings Call

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its financial results for its fiscal third quarter ended May 31, 2019. “We continued to report strong sales in our third quarter and now have distribution in all ten provinces,” Organigram CEO Greg Engel said in the news release. “In our fiscal year to date, we have generated strong operating and financial results, placing us among the leaders in the Canadian industry. While we saw a temporary reduction in yield per plant in Q3 due to temporary changes in growing…

Continue Reading

WednesdayJul 10, 2019 9:26 am

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Collaborates with Lift & Co. Corp. (TSXV: LIFT) (OTCQB: LFCOF) to Bring Brand-Specific Training to Cannabis Retailers

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc, a leading licensed producer of cannabis, this morning announced a collaboration with Lift & Co. Corp. (TSXV: LIFT) (OTCQB: LFCOF) to support the launch of Lift & Co.’s CannSell retail training program. As Canada’s first branded cannabis educational program, CannSell’s retail certification program encourages the responsible sale of cannabis and is offered in seven provinces and one territory. The rollout of the Organigram-branded module began in June. Among other highlights, the module will provide digital training on the company’s innovative three-tiered growing methodology to budtenders across Canada. “Education…

Continue Reading

TuesdayJul 09, 2019 10:28 am

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces Development of Nano-Emulsification Technology for Liquid and Powdered Cannabis Products

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc, a leading licensed producer of cannabis, on Monday announced that it has developed a proprietary nano-emulsification technology for the production of both liquid and powdered cannabinoid products in anticipation of Canada’s legalization of adult use recreational cannabis edibles and consumer demand for cannabis-infused beverages. According to the update, Organigram is planning, in early 2020, to launch a variety of dried powder formulation beverage products in Canada in addition to its previously announced plans to launch a range of premium cannabinoid-infused chocolates. “This is an exciting time for cannabis…

Continue Reading

TuesdayJul 02, 2019 9:30 am

QualityStocksNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) to Release Q3 2019 Earnings, Host Conference Call

Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., this morning announced that before market open on Monday, July 15, 2019, the company will report its third quarter earnings results for its fiscal year ended August 31, 2019. In addition, the company will be hosting a conference call to discuss the results on July 15 at 8:00 AM ET. To join the call, dial 1-866-211-4093 for the toll-free North America line or 647-689-6727 for the international line. Following the call, a replay of the webcast will be available for 90 days at Organigram.ca/Investors. To register to join the webcast,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered